| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ONCONOVA THERAPEUTICS INC | 241,644 | 202,000 | 0.04% | ||
| 2 | NEXVET BIOPHARMA PUB LTD CO | 154,840 | 602,000 | 0.13% | ||
| 3 | ARADIGM CORP | 576,208 | 893,000 | 0.20% | ||
| 4 | ONCONOVA THERAPEUTICS INC | 316,386 | 962,000 | 0.21% | ||
| 5 | AKARI THERAPEUTICS PLC | 95,011 | 1,052,000 | 0.23% | ||
| 6 | ANAPTYSBIO INC | 50,000 | 1,388,000 | 0.30% | ||
| 7 | Aldeyra Therapeutics Inc | 291,230 | 1,456,000 | 0.32% | ||
| 8 | EIGER BIOPHARMACEUTICALS INC | 138,331 | 1,584,000 | 0.35% | ||
| 9 | ADR - Nabriva Therapeutics AG- Usd | 176,710 | 2,121,000 | 0.46% | ||
| 10 | Sunesis Pharmaceuticals, Inc. | 525,000 | 2,153,000 | 0.47% | ||
| 11 | BELLEROPHON THERAPEUTICS INC | 1,857,143 | 2,767,000 | 0.60% | ||
| 12 | Syndax Pharmaceuticals Inc | 234,220 | 3,213,000 | 0.70% | ||
| 13 | CYMABAY THERAPEUTICS INC | 777,202 | 3,342,000 | 0.73% | ||
| 14 | PUMA BIOTECHNOLOGY | 100,000 | 3,720,000 | 0.81% | ||
| 15 | Strongbridge Biopharma plc | 940,000 | 4,465,000 | 0.98% | ||
| 16 | KURA ONCOLOGY INC | 533,251 | 4,693,000 | 1.03% | ||
| 17 | LA JOLLA PHARMACEUTICAL CO | 167,400 | 4,997,000 | 1.09% | ||
| 18 | MIRATI THERAPEUTICS INC COM | 1,037,994 | 5,398,000 | 1.18% | ||
| 19 | SEATTLE GENETICS INC | 100,000 | 6,286,000 | 1.37% | ||
| 20 | ALEXION PHARMACEUTIC | 75,000 | 9,093,000 | 1.99% | ||
| 21 | ALNYLAM PHARMACEUTICALS INC | 250,000 | 12,813,000 | 2.80% | ||
| 22 | INCYTE CORP | 100,000 | 13,367,000 | 2.92% | ||
| 23 | AQUINOX PHARMACEUTICALS INC | 877,753 | 14,650,000 | 3.20% | ||
| 24 | PTC THERAPEUTICS INC | 1,500,000 | 14,760,000 | 3.23% | ||
| 25 | BLUEPRINT MEDICINES CORP COM | 770,159 | 30,799,000 | 6.73% | ||
| 26 | BEIGENE LTD | 850,000 | 31,119,000 | 6.80% | ||
| 27 | MEDICINES CO | 683,700 | 33,433,000 | 7.31% | Call | |
| 28 | Esperion Therapeutics Inc | 1,275,000 | 45,020,000 | 9.84% | ||
| 29 | MEDICINES CO | 1,215,000 | 59,414,000 | 12.98% | ||
| 30 | CLOVIS ONCOLOGY INC | 1,000,000 | 63,670,000 | 13.91% | ||
| 31 | AVEXIS INC COM | 1,028,763 | 78,217,000 | 17.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-005338, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
